Home/Academy/Journal Finder/American Journal of Clinical Oncology
American Journal of Clinical Oncology
Wolters Kluwer (Lippincott Williams & Wilkins)
Multidisciplinary clinical oncology for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists and pediatric oncologists, with priority for combined-modality management of cancer
Overview
American Journal of Clinical Oncology is published by Wolters Kluwer (Lippincott Williams & Wilkins). Multidisciplinary clinical oncology for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists and pediatric oncologists, with priority for combined-modality management of cancer
Key information
ISSNs, NLM abbreviation, start year and MEDLINE status are from the NLM Catalog (NLM ID 8207754). Editor-in-Chief, frequency, format and readership as listed on Wolters Kluwer’s Ovid pages and the 2027 Lippincott media kit.
Aims & scope
AJCO gives priority to high-quality research on the combined-modality, multidisciplinary management of cancer. It also seeks to highlight:
- Combined-modality, multidisciplinary cancer management
- Translational research
- Outcome studies
- Cancer-related health policy
- Cost-utility analyses
- Selected opinion pieces and review articles
Case reports are not considered for publication.
Original Article
- Text
- ≤3,500 words (excludes abstract, references, tables, legends)
- Abstract
- ≤250 words, structured (Objectives, Methods, Results, Conclusions)
- References
- No limit stated
- Tables / figures
- ≤6 combined; more as Supplemental Digital Content
Review Article
- Text
- ≤4,000 words (excludes abstract, references, tables, legends)
- Abstract
- ≤250 words, unstructured
- References
- No limit stated
- Tables / figures
- ≤6 combined; more as Supplemental Digital Content
Cancer Management Controversy
- Text
- ≤2,000 words (excludes references)
- Abstract
- None
- References
- No limit stated
- Tables / figures
- ≤2
Opinion Piece
- Text
- ≤1,500 words (excludes references)
- Abstract
- None
- References
- No limit stated
- Tables / figures
- 1
Correspondence
- Text
- ≤750 words (excludes references)
- Abstract
- Not stated
- References
- No limit stated
- Tables / figures
- 1
Important notes
- Word limits exclude the abstract, references, table titles, figure legends and footnotes unless stated otherwise.
- Requirements vary by article type and are set by the publisher — confirm against the live author guidelines before submitting.
- Case reports are not considered.
General formatting rules that apply across article types. Specific word, abstract, reference and figure limits vary by article type — see the Article types tab for those.
General requirements
Manuscript template
No manuscript template is mentioned; follow the Instructions for Authors. The PaperPal Preflight check is recommended before submission
Information on the submission process and the ethics and publication standards American Journal of Clinical Oncology applies.
Submission process
Ethics & publication standards
Original, unpublished work not under consideration elsewhere. Conflict-of-interest disclosure follows ICMJE recommendations. Preprints are accepted (declare them at submission). Use of AI tools must be disclosed in the Methods.
Author declarations
- Conflicts of Interest and Source of FundingOn the title page under that heading: all financial, consultant, institutional and other relationships for each author, or “none declared”; all funding sources
- Funder disclosureTitle page must state any funding from NIH, Wellcome Trust, HHMI or other organisations
- Informed consent and patient anonymityStudies with human subjects need informed consent and institutional approval; identifying details need signed patient permission, stated in the Methods or Acknowledgments
- Copyright transfer agreementEvery author completes it in Editorial Manager; it includes the ICMJE conflict-of-interest disclosure
- PermissionsWritten permission from the copyright owner for any previously published quotations, tables or illustrations; fees are the author’s responsibility
- Use of AI toolsWhich tool was used and how, in the Methods (or similar) section
- PreprintsIndicate in the Editorial Manager submission if the manuscript was shared as a preprint
- AcknowledgmentsAll forms of support, including pharmaceutical industry support
From the journal’s Instructions for Authors. Manuscripts that do not follow the instructions are returned for technical revision before peer review.
Author guidelines
Read the complete and latest author instructions on the journal website.
View author guidelinesData availability
No data-sharing or data-availability statement is required in the Instructions for Authors. NIH-funded accepted manuscripts are deposited in PubMed Central by the publisher.
Declaration headings are taken from American Journal of Clinical Oncology's own submission guidelines — check the live author guidelines before submitting, as they can change.
Sample articles
Recent, relevant articles published in American Journal of Clinical Oncology. These examples help you understand the journal's scope, style and expected quality — we only list one once its title, DOI, year and article type are verified against the publisher's own page.
Filter examples
Article type
Learn from examples
- Review the structure, formatting and presentation style the journal actually publishes.
- Use examples together with the Article types and Manuscript specs tabs, not as a substitute for the journal's own guidelines.
- Check article-type-specific requirements before drafting.
All six confirmed against their PubMed records (title, authors, date, volume, pages and DOI). Section labels follow the journal’s table of contents; the three newest articles are online ahead of print and not yet assigned to a section.
General stages a manuscript moves through at most peer-reviewed journals — this sequence is standard academic-publishing practice, not a claim we've verified against American Journal of Clinical Oncology's own workflow. Durations below are shown only where the publisher has actually disclosed them.
Manuscript submitted via the journal's submission system.
Administrative and scope check by the editorial office.
Editor decides whether to send the manuscript for peer review.
External review by expert referees.
Accept, minor/major revision, or reject.
Author submits a revised manuscript, if requested.
Editor confirms acceptance.
Online-first, then the print/issue assignment if applicable.
Key timeline statistics
Timeline by article type
Not disclosed. Wolters Kluwer does not publish turnaround times for AJCO. Figures seen online (such as about 4 weeks to first decision) usually belong to ASCO’s Journal of Clinical Oncology, a different journal.
Factors that may affect timeline
- Type and complexity of the study
- Speed of author response to reviewer comments
- Number of revision rounds
- Availability of expert reviewers
- Editorial and production workload
- Compliance with the journal's own guidelines
General tips for faster processing
- Confirm the manuscript fits the journal's scope before submitting
- Follow the author guidelines and formatting requirements closely
- Respond to reviewer comments completely and promptly
- Submit all required documents and declarations at the time of submission
The stage sequence and general tips above reflect typical academic-publishing practice, not data we've verified against American Journal of Clinical Oncology specifically. Any duration we haven't independently confirmed from the publisher reads as "not yet verified" rather than an estimate.
Indexing and abstracting services
Scopus coverage runs from 1982 to date. Web of Science: Science Citation Index Expanded and Current Contents/Clinical Medicine. Also in Embase (Excerpta Medica), MEDLINE/PubMed (Index Medicus) and BIOSIS Previews. EBSCOhost carries the MEDLINE records (citations and abstracts); full text is on Wolters Kluwer’s Ovid platform. Catalogued in OCLC WorldCat (OCLC 07580250 print, 47641066 online). Not in DOAJ, which lists only fully open-access journals. ProQuest coverage is not confirmed.
Citation metrics
Only the figures listed are on record here. Confirm on JCR, Scopus or SCImago before citing.
Only the figures listed are on record here. Confirm on JCR, Scopus or SCImago before citing.
Only the figures listed are on record here. Confirm on JCR, Scopus or SCImago before citing.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Journal quartile
Scopus and Web of Science classify journals into their own category sets — we show the one subject category we've confirmed rather than listing categories we haven't checked.
Additional metrics
CiteScore details (2025)
Metric notes
- Impact Factor 1.8 (2025 JCR; 5-year 1.9) is Clarivate’s figure, as listed by Wolters Kluwer Ovid; it ranks 252 of 326 in JCR’s Oncology category (Q4).
- SJR, the Q3 quartile and the h-index (95) are from SCImago (2025). SCImago ranked the journal Q2 in Oncology up to 2023.
- CiteScore (2.7 in 2025, 3.1 in 2024, peaks of 5.0 in 2016 and 2021) is the Scopus figure as reported by MOST Wiedzy and Journal Searches. The 386 documents for 2022–2025 (81, 88, 88 and 129) are SCImago’s count; Scopus’s own denominator is slightly lower because it leaves out some non-peer-reviewed items. The citation count and SNIP need a Scopus login and are not shown.
AJCO is a subscription journal with an optional open-access route. Open access is chosen at submission and has no effect on peer review or acceptance.
Publication charges (APC)
Additional charges
Check current fees
Publication-charge and open-access policy pages change independently of this profile.
Fees and fundingLicence & copyright
- Licence: Open-access articles: CC BY-NC-ND; CC BY for authors with approved funders that require it
- Copyright: Subscription articles: authors transfer copyright to Wolters Kluwer. Open-access articles: authors keep copyright and grant Wolters Kluwer an exclusive licence to publish
Based on what Wolters Kluwer (Lippincott Williams & Wilkins) has publicly stated for American Journal of Clinical Oncology as of our last check (read Nov 2026) — verify current fees and policy on the journal website before budgeting or submitting.
- Best fit for manuscripts in multidisciplinary clinical oncology for cancer surgeons, radiation oncologists, medical oncologists, gynecologic oncologists and pediatric oncologists, with priority for combined-modality management of cancer — not a narrow subspecialty-only readership.
- No manuscript template is mentioned; follow the Instructions for Authors. The PaperPal Preflight check is recommended before submission
- Formatting is article-type specific — see the Article types tab before drafting, rather than assuming one universal word limit.
- Reference style: AMA style (AMA Manual of Style, 11th ed.): numbered in order of appearance; list the first three authors then “et al.” when there are more than three; journal names abbreviated as in Index Medicus; unpublished data cited in parentheses in the text
These notes are Pubrica's own read of the journal's published guidelines, not a claim about editorial preference or acceptance likelihood.
Verified against the NLM Catalog record (ISSNs, abbreviation, start year, MEDLINE status), the journal’s Instructions for Authors (edmgr.ovid.com/ajco), Wolters Kluwer’s product pages and PubMed records for the sample articles.